B+
Bull case
0%
Probability
Target price
$7.20
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
SENS
SenseonicsFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
The best post-earnings bull argument is that Q1 showed real commercialization traction: revenue nearly doubled year over year, U.S. revenue more than doubled, gross margin expanded to 59%, and FY2026 revenue guidance was raised [#8-K-2026-05-07].
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.0.
What can break
Commercial transition risk remains high as Senseonics takes Eversense sales and marketing in-house in Europe and absorbs the U.S. model shift.
Momentum
51
Value
36
Sentiment
32
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.60 · Bull $7.20 · Bear $4.10Analysis 2026-05-09; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-09 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $13.67
Why
Momentum51 · Δ7d -25.3
Value36 · Δ7d +0.0
Sentiment32 · Δ7d +3.5
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta +0.0.
Contradictions & invalidation
- • Commercial transition risk remains high as Senseonics takes Eversense sales and marketing in-house in Europe and absorbs the U.S. model shift.
- • Europe launch, reimbursement, tender timing, and additional AID compatibility are all execution-sensitive in medtech and could slip or scale slower than hoped.
- • The bear case is that the good topline still sits inside a cash-burning transition story: SG&A surged to $30.2M as Senseonics absorbed commercialization from Ascensia, net loss widened to $32.3M, and the stock now has to prove that DTC spending, Europe handoff, and AID partnerships can translate into durable demand rather than one strong quarter [#10-Q-2026-05-07].
Catalyst clock
2026-05-20
Q1 print lifted FY2026 revenue outlook but post-print setup still needs confirmation
Lead driver: Value · See fundamentals
Momentum
51
8% active weight
Current posture
7d trendImproving
Δ7d
-25.3
Δ21d
-33.0
Value
36
47% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
-0.1
Sentiment
32
45% active weight
Current posture
7d trendImproving
Δ7d
+3.5
Δ21d
+18.4
Why this grade
Composite grade F. Momentum 50.7 / Value 36.3 / Sentiment 31.9
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-05-09. Scenario method
Most likely
B
Base case
1%
Probability
Target price
$5.60
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
B-
Bear case
0%
Probability
Target price
$4.10
Analysis reference price unavailable
Analysis 2026-05-09 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$397.08M
Beta
0.99
Shares Out
52.87M
P/E (TTM) · Derived
-4.5
P/S (TTM)
8.47
P/FCF (TTM) · Derived
-3.69
Rev YoY
+117.8%
EPS YoY
+78.0%
Gross Margin
+54.9%
Op Margin
-223.2%
Net Debt
-$52.97M
Current Ratio
6.74
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data